A decade of studies provide a growing evidence base that increasing the power of the brain’s gamma rhythms could help fight Alzheimer’s, and perhaps other neurological diseases.

Lifeward (Nasdaq:LFWD) announced today that it received FDA 510(k) clearance for its latest-generation personal exoskeleton device, ReWalk 7.

Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic navigation.

Perfuze announced today that it received FDA 510(k) clearance for its Zipline access catheter and secured significant funding.

Using Nvidia and GE Healthcare technology, the robotic surgery system is intended to help doctors detect lung cancer earlier.

A new, highly efficient process for performing this conversion could make it easier to develop therapies for spinal cord injuries or diseases like ALS.

A researcher at Northeastern University has found a groundbreaking new way to diagnose people with sleep apnea that could open the door for mass screenings of a sleep disorder that affects millions of people.

A team of Ohio University researchers have made a groundbreaking development in the fight against obesity. In a study recently published in Obesity, the researchers highlight a protein that is naturally produced in the body but could potentially be applied to combat weight gain and improve metabolic health in patients with obesity.